Based in Wuhan, Affinibody Life Science Co., Ltd. develops, manufactures and supplies key enzymes, antibodies and biochemical reagents. Powered by AI-assisted protein design and NMR-guided directed evolution, we advance enzymes for research, diagnostics and genetically modified plants, as well as nanobodies for applications including cell therapy, multispecific antibodies and antibody-mediated protein degradation.
Serving green manufacturing, human health and scientific research, Affinibody combines craftsmanship with a commitment to world-class products. We offer better choices for research, industry and everyday life, supporting sustainable development.
Directed evolution rapidly improves selected protein properties through mutant library construction and high-throughput screening. Affinibody has developed an NMR-guided directed evolution approach, an advanced strategy for protein engineering. It supports enzyme optimization, antibody humanization and affinity improvement to produce better-performing enzymes and antibodies.
Antibodies are immunoglobulins that specifically recognize targets for diagnostic and therapeutic applications. Their variable domains contain framework regions (FRs) and complementarity-determining regions (CDRs), typically arranged as FR1–CDR1–FR2–CDR2–FR3–CDR3–FR4. The framework primarily stabilizes the structure. Affinibody combines AI and structural biology to design improved artificial frameworks for high-performance antibody-like molecules, expanding options for diagnostics and therapeutics.
High-throughput screening uses automation to identify positive hits from millions of samples. Affinibody uses evolutionary selection in place of conventional screening, enabling low-cost, automated enrichment of positive targets and clones.
Scientific innovation depends on reliable research tools. Drawing on hands-on research experience, Affinibody optimizes and develops biochemical reagents to give researchers better products and support scientific progress.
Affinibody Life Science Co., Ltd. develops better enzyme and antibody products to support green manufacturing, human health and life science research, contributing to a more sustainable future.
